Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 3 of 3
Full-Text Articles in Health Law and Policy
Mid-Atlantic Ethics Committee Newsletter, Fall 2006-Winter 2007
Mid-Atlantic Ethics Committee Newsletter, Fall 2006-Winter 2007
Mid-Atlantic Ethics Committee Newsletter
No abstract provided.
Mid-Atlantic Ethics Committee Newsletter, Summer 2006
Mid-Atlantic Ethics Committee Newsletter, Summer 2006
Mid-Atlantic Ethics Committee Newsletter
No abstract provided.
Racially-Tailored’ Medicine Unraveled, Sharona Hoffman
Racially-Tailored’ Medicine Unraveled, Sharona Hoffman
Faculty Publications
In June 2005, the FDA approved BiDil, a heart failure medication that is labeled for use only by African-Americans and thus is the first treatment of its kind. The drug likely portends a future of growing interest in "race-based" medicine. This phenomenon is emerging at the same time that scientists, in light of the Human Genome Project, are reaching an understanding that "race" has no biological meaning, and consequently, "racially-tailored" medicine is both puzzling and troubling.
This Article explores the reasons for the new focus on "racial-profiling" in medicine. It analyzes the risks and dangers of this approach, including medical …